Investing.com UK - Financial Markets Worldwide
⭐ Start off 2025 with a powerful boost to your portfolio: January’s freshest AI-picked sharesUnlock shares

Meta Platforms To $150? Plus This Analyst Predicts $239 For HCA Healthcare

Published 24/10/2022, 13:27
© Reuters. Meta Platforms To $150? Plus This Analyst Predicts $239 For HCA Healthcare
IXIC
-
HCA
-
META
-
TGTB34
-
H1CA34
-
HCA
-

  • B of A Securities cut the price target on Meta Platforms, Inc. (NASDAQ: META) from $196 to $150. B of A Securities analyst Justin Post downgraded the stock from Buy to Neutral. Meta shares fell 0.8% to $128.93 in pre-market trading.
  • Citigroup (NYSE:C) raised the price target for Schlumberger (NYSE:SLB) Limited (NYSE: SLB) from $50 to $60. Citigroup analyst Scott Gruber maintained a Buy rating on the stock. Schlumberger shares fell 0.5% to $50.15 in pre-market trading.
  • RBC Capital cut the price target on HCA (NYSE:HCA) Healthcare, Inc. (NYSE: HCA) from $249 to $239. HCA Healthcare shares rose 0.3% to $197.25 in pre-market trading.
  • Keybanc lowered the price target for Okta, Inc. (NASDAQ: OKTA) from $100 to $70. Okta shares rose 0.5% to $55.26 in pre-market trading.
  • Needham cut the price target for Euronet Worldwide, Inc. (NASDAQ: EEFT) from $140 to $105. Euronet Worldwide shares rose 7.7% to close at $82.44 on Friday.
  • Barclays (LON:BARC) slashed the price target on Qorvo, Inc. (NASDAQ: QRVO) from $120 to $90. Qorvo shares fell 1.8% to $83.98 in pre-market trading.
  • Jefferies cut the price target on Williams-Sonoma, Inc. (NYSE: WSM) from $160 to $100. Williams-Sonoma shares fell 2.6% to $114.61 in pre-market trading.
Check out this: This Analyst With 90% Accuracy Rate Slashes PT On Snap; Here Are 5 Stock Picks For Last Week From Benzinga's Most Accurate Analysts

Don’t forget to check out our premarket coverage here .

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.